Xcout Intel
Novadip
Novadip Biosciences is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in Belgium, focusing on innovative tissue regeneration and biopharmaceuticals.
Subscribe to see Novadip’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Novadip at a glance
Novadip is a biotechnology company headquartered in Belgium. It has raised at least $61.2M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $39.1M in November 2022. Xcout tracks 15 named people at Novadip, including Soumya Chandramouli (Chief Financial Officer).
Novadip leadership
- Soumya ChandramouliChief Financial Officer
- Neil JohnsonChief Technology Officer
- Judy AshworthChief Medical Officer
- Siegfried EbnerChief Operations Officer
- Denis DufraneCo-Founder, Chief Executive Officer & Board Member
- Gaëtane MetzVP Quality-EHS
9 more named people on record for Novadip, with roles, board committees and tenure — see the full roster →
Novadip funding rounds
At least $61.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $39.1M | — | |
| — | $22.1M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Novadip competitors
A few of Novadip's closest competitors — see the full list of competitors and alternatives →
Endogena Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Zürich, Switzerland, that discovers and develops first-in-class endogenous regenerative medicines to repair tissues.
NovaGo Therapeutics is a clinical-stage Swiss biotech company located in Schlieren that develops human antibody therapeutics focused on nerve growth and regeneration.
Celyad Oncology is a biopharmaceutical company headquartered in Mont-Saint-Guibert, Belgium, focused on the development of innovative therapies.
Kadimastem Ltd. is a clinical-stage cell therapy company headquartered in Ness Ziona, Israel, focused on developing advanced cell-based therapeutic treatments.
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Eluciderm Inc. is a clinical-stage regenerative medicine small-molecule pharmaceutical company that uses a selective multi-PARP modulation platform to alter the body’s response to inflammation and injury. The company develops therapeutics designed to enable organized tissue regeneration, enhance wound healing, and minimize scarring following trauma.
Get Novadip's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Novadip in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access